빔 테라퓨틱스 (BEAM)

Dec 20, 2024

Here's Why We're Not At All Concerned With Beam Therapeutics' (NASDAQ:BEAM) Cash Burn Situation - Simply Wall St

Dec 20, 2024

Dec 19, 2024

Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.

Dec 19, 2024

Dec 18, 2024

Beam Therapeutics (BEAM) Stock Dips Amid Biotech Sector Decline - GuruFocus.com

Dec 18, 2024

Dec 17, 2024

Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 17, 2024

Dec 17, 2024

Beam Therapeutics CEO to Present at J.P. Morgan Healthcare Conference: Precision Gene Editing Spotlight - StockTitan

Dec 17, 2024

Dec 17, 2024

State Street Corp Purchases 437,402 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM) - MarketBeat

Dec 17, 2024

Dec 15, 2024

Beam Therapeutics Inc. (NASDAQ:BEAM) Sees Large Decline in Short Interest - MarketBeat

Dec 15, 2024

Dec 15, 2024

Beam Therapeutics' SWOT analysis: base editing pioneer faces competitive gene therapy market - Investing.com

Dec 15, 2024

Dec 15, 2024

Beam Therapeutics' SWOT analysis: base editing pioneer faces competitive gene therapy market By Investing.com - Investing.com South Africa

Dec 15, 2024

Dec 13, 2024

Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains - AOL

Dec 13, 2024

Dec 12, 2024

Brokers Issue Forecasts for BEAM FY2024 Earnings - MarketBeat

Dec 12, 2024

Dec 11, 2024

Beam Therapeutics announces new data from BEACON Phase 1/2 trial of BEAM-101 - MSN

Dec 11, 2024

Dec 11, 2024

Beam Therapeutics Appoints Sravan Emany as New CFO, Shares Up - MSN

Dec 11, 2024

Dec 11, 2024

Why Beam Therapeutics (BEAM) Is the Worst ARK Stock to Buy According to Short Sellers - MSN

Dec 11, 2024

Dec 11, 2024

Beam Therapeutics (NASDAQ:BEAM) Rating Increased to Hold at Cantor Fitzgerald - MarketBeat

Dec 11, 2024

Dec 10, 2024

10 Worst ARK Stocks To Buy According to Short Sellers - Insider Monkey

Dec 10, 2024

Dec 09, 2024

Beam Therapeutics shares hold Outperform amid clinical data By Investing.com - Investing.com Canada

Dec 09, 2024

Dec 09, 2024

Beam Therapeutics shares hold Outperform amid clinical data - Investing.com

Dec 09, 2024

Dec 09, 2024

Beam Therapeutics Advances BEAM-101 Therapy for Sickle Cell - TipRanks

Dec 09, 2024

Dec 08, 2024

ASH: Beam’s Base Editor Efficacy In Sickle Cell Disease Holds Up - News & Insights

Dec 08, 2024

Dec 08, 2024

Beam Therapeutics Achieves Breakthrough in Sickle Cell Treatment with Promising ESCAPE Platform Data - StockTitan

Dec 08, 2024

Dec 08, 2024

Beam Therapeutics Presents New Non-human Primate (NHP) Data - GlobeNewswire

Dec 08, 2024

Dec 08, 2024

Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for - The Bakersfield Californian

Dec 08, 2024

Dec 08, 2024

Charles Schwab Investment Management Inc. Boosts Stake in Beam Therapeutics Inc. (NASDAQ:BEAM) - MarketBeat

Dec 08, 2024

Dec 07, 2024

Beam Therapeutics (NASDAQ:BEAM) Stock Price Up 8.6%Here's Why - MarketBeat

Dec 07, 2024

Dec 07, 2024

BEAMBeam Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Dec 07, 2024

Dec 07, 2024

Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting - The Manila Times

Dec 07, 2024

Dec 07, 2024

Beam Therapeutics Announces New Data from BEACON Phase 1/2 - GlobeNewswire

Dec 07, 2024

Dec 07, 2024

Beam Therapeutics Reports Breakthrough Clinical Data for Sickle Cell Gene Therapy BEAM-101 - StockTitan

Dec 07, 2024

Dec 07, 2024

20,800 Shares in Beam Therapeutics Inc. (NASDAQ:BEAM) Acquired by Polar Asset Management Partners Inc. - MarketBeat

Dec 07, 2024

Dec 06, 2024

Beam Therapeutics Inc. Appoints Sravan K. Emany as Chief Financial Officer, Effective December 19, 2024 - Marketscreener.com

Dec 06, 2024

Dec 06, 2024

Beam Therapeutics Names Sravan K. Emany as CFO - TipRanks

Dec 06, 2024

Dec 06, 2024

Beam Therapeutics names Sravan K. Emany as new CFO - Investing.com

Dec 06, 2024

Dec 06, 2024

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer - The Manila Times

Dec 06, 2024

Dec 06, 2024

Beam Therapeutics Names Former Ironwood CFO & Banking Veteran Sravan Emany as New Finance Chief - StockTitan

Dec 06, 2024

Dec 05, 2024

Tom Jede - The Business Journals

Dec 05, 2024

Dec 05, 2024

Why Is Beam Therapeutics (BEAM) Down 2.3% Since Last Earnings Report? - Yahoo Finance

Dec 05, 2024

Dec 05, 2024

Redmile Group LLC Has $39.47 Million Stake in Beam Therapeutics Inc. (NASDAQ:BEAM) - MarketBeat

Dec 05, 2024

Dec 05, 2024

Beam Therapeutics adds Merck executive to board By Investing.com - Investing.com Canada

Dec 05, 2024

Dec 05, 2024

Erste Asset Management GmbH Makes New $544,000 Investment in Beam Therapeutics Inc. (NASDAQ:BEAM) - MarketBeat

Dec 05, 2024

Dec 05, 2024

Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Sold by Fmr LLC - MarketBeat

Dec 05, 2024

Dec 04, 2024

Beam Therapeutics Inc. Announces the Appointment of Chirfi Guindo to Its Board of Directors - Marketscreener.com

Dec 04, 2024

Dec 04, 2024

Beam Therapeutics adds Merck executive to board - Investing.com

Dec 04, 2024

Dec 04, 2024

Beam Therapeutics Expands its Board of Directors with Appointment of Chirfi Guindo, Global Biopharma Strategy and Commercial Leader - The Manila Times

Dec 04, 2024

Dec 04, 2024

Beam Therapeutics Expands its Board of Directors with - GlobeNewswire

Dec 04, 2024

Dec 04, 2024

Beam Therapeutics Strengthens Board with Merck's Chief Marketing Officer Chirfi Guindo - StockTitan

Dec 04, 2024

Dec 03, 2024

Beam Therapeutics Breaks Below 200-Day Moving AverageNotable for BEAM - Nasdaq

Dec 03, 2024

Dec 03, 2024

Walleye Capital LLC Raises Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM) - MarketBeat

Dec 03, 2024

Dec 02, 2024

(BEAM) Trading Report - Stock Traders Daily

Dec 02, 2024

Dec 02, 2024

20,892 Shares in Beam Therapeutics Inc. (NASDAQ:BEAM) Acquired by Intech Investment Management LLC - MarketBeat

Dec 02, 2024